Brazil’s health authority Anvisa said that a volunteer in a clinical trial of the COVID-19 vaccine developed by Oxford University and AstraZeneca had died but added the trial would continue.
Oxford confirmed the plan to keep testing, saying in a statement that after careful assessment “there have been no concerns about the safety of the clinical trial.”
The Federal University of Sao Paulo said an independent review committee had also recommended the trial continue. The university earlier confirmed the volunteer was Brazilian but gave no further personal details.
“Everything is proceeding as expected, without any record of serious vaccine-related complications involving any of the participating volunteers,” the Brazilian university said in a statement.